Cook Pharmica LLC Signs First Client

Bloomington, Ind. - Cook Pharmica, the contract biopharmaceutical manufacturing division of Cook Medical, announced today that it has signed an agreement with its first client, Monsanto Company, to perform small-scale manufacturing of bacterial-produced proteins in support of safety assessments of biotechnology-based crops. Manufacturing activities will be performed in Cook Pharmica's development laboratory within its Bloomington, Ind. facility.

"Cook Pharmica is pleased to be partnering with Monsanto and honored to be selected as their contract manufacturer," said Jerry Arthur, president of Cook Pharmica. "This is a significant milestone for our company and a tribute to all of the hard work performed by our employees and team members who helped bring this company to fruition."

Terms of the agreement were not released.

About Cook Pharmica:
Cook Pharmica (www.cookpharmica.com) is a contract biopharmaceutical manufacturing organization developing and manufacturing mammalian cell culture-based pharmaceuticals for pre-clinical through commercial use. They also offer cell line/strain development, clone selection, cell line adaptation, media optimization, process development, analytical development, cell banking/storage, stability testing/storage, and regulatory submission support.

About Cook Medical
Cook Medical, the world's largest privately held medical device company with 15 manufacturing facilities and more than 6,000 employees worldwide, has pioneered countless innovative minimally invasive interventional technologies for diagnostic and therapeutic procedures and is leading the way in the convergence of devices, drug-eluting coatings, bio-derived materials, and cell and gene therapies that will further benefit patients in the 21st Century. One of the fastest-growing medical technology companies in the world since its founding in 1963, Cook is recognized as a leading developer, manufacturer and global distributor of cutting-edge interventional therapies in the fields of radiology, cardiology, urology, aortic intervention, peripheral intervention including peripheral vascular, bone access and oncology, women's health and other gender-specific procedures, critical care medicine, surgery and soft tissue repair, gastroenterology, and cellular and genetic therapies. With global headquarters in Bloomington, Ind., the company won the prestigious Medical Device Manufacturer of the Year Award for 2006 from Medical Device & Diagnostic Industry magazine. For more information, visit (www.cookmedical.com/)

About Monsanto Company:
Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information, please visit: www.monsanto.com.

MEDIA CONTACT:
David McCarty
Director of Public Relations
Cook Medical - 812-339-2235 ext. 2387
Email: dave.mccarty@cookmedical.com

Back to Previous Page